Trial Profile
Phase II trial of AD04 in patients with Alzheimer's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Apr 2015
Price :
$35
*
At a glance
- Drugs AD 04 Advantage Therapeutics (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors AFFiRiS
- 14 Apr 2015 New trial record